Loading clinical trials...
Loading clinical trials...
Study of Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy
Conditions
Interventions
Shexiang Baoxin pill
SBP placebo
+6 more
Start Date
June 1, 2017
Primary Completion Date
December 1, 2018
Completion Date
February 1, 2019
Last Updated
April 4, 2017
NCT07386418
NCT07163858
Lead Sponsor
Jun Li
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions